142 related articles for article (PubMed ID: 14966921)
21. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis.
Mulder JW; Wielenga VJ; Polak MM; van den Berg FM; Adolf GR; Herrlich P; Pals ST; Offerhaus GJ
Gut; 1995 Jan; 36(1):76-80. PubMed ID: 7534253
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis.
Amirghofran Z; Jalali SA; Hosseini SV; Vasei M; Sabayan B; Ghaderi A
J Gastrointest Cancer; 2008; 39(1-4):73-8. PubMed ID: 19333790
[TBL] [Abstract][Full Text] [Related]
23. CD44 in colon cancer.
Herrlich P; Pals S; Ponta H
Eur J Cancer; 1995; 31A(7-8):1110-2. PubMed ID: 7577002
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of serum levels of CD44 variant exons 8-10 protein in colorectal cancer.
Yamaguchi A; Goi T; Taguchi S; Ohtaki N; Seki K; Hirose K; Nakagawara G; Urano T; Furukawa K
J Gastroenterol; 1998 Jun; 33(3):349-53. PubMed ID: 9658313
[TBL] [Abstract][Full Text] [Related]
25. Splice variants of the cell surface glycoprotein CD44 associated with metastatic tumour cells are expressed in normal tissues of humans and cynomolgus monkeys.
Heider KH; Mulder JW; Ostermann E; Susani S; Patzelt E; Pals ST; Adolf GR
Eur J Cancer; 1995 Dec; 31A(13-14):2385-91. PubMed ID: 8652273
[TBL] [Abstract][Full Text] [Related]
26. Expression of CD44 and the pattern of CD44 alternative splicing in uveal melanoma.
Danen EH; ten Berge PJ; van Muijen GN; Jager MJ; Ruiter DJ
Melanoma Res; 1996 Feb; 6(1):31-5. PubMed ID: 8640067
[TBL] [Abstract][Full Text] [Related]
27. Splice variants of CD44 in human cervical cancer stage IB to IIB.
Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
[TBL] [Abstract][Full Text] [Related]
28. Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas.
Stoll C; Baretton G; Soost F; Terpe HJ; Domide P; Löhrs U
Oral Oncol; 1999 Sep; 35(5):484-9. PubMed ID: 10694948
[TBL] [Abstract][Full Text] [Related]
29. Unaltered strong immunohistochemical expression of CD44-v6 and -v5 isoforms during development and progression of oral squamous cell carcinomas.
Piffkò J; Bànkfalvi A; Klauke K; Dreier R; Joos U; Böcker W; Schmid KW
J Oral Pathol Med; 1996 Oct; 25(9):502-6. PubMed ID: 8959559
[TBL] [Abstract][Full Text] [Related]
30. Serological evaluation of soluble CD44 in renal cancer.
Kan M; Kanayama H; Naruo S; Tsuji M; Kojima K; Kurokawa Y; Kagawa S
Jpn J Cancer Res; 1996 Nov; 87(11):1191-4. PubMed ID: 9045950
[TBL] [Abstract][Full Text] [Related]
31. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.
Karabulut M; Gunaldi M; Alis H; Afsar CU; Karabulut S; Serilmez M; Akarsu C; Seyit H; Aykan NF
Clin Transl Oncol; 2016 Feb; 18(2):160-71. PubMed ID: 26184725
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
Sliutz G; Tempfer C; Winkler S; Kohlberger P; Reinthaller A; Kainz C
Br J Cancer; 1995 Dec; 72(6):1494-7. PubMed ID: 8519665
[TBL] [Abstract][Full Text] [Related]
33. The positive relationship between the expression of CD44 variant 6 and prognosis in colorectal cancer.
Nihei Z; Ichikawa W; Kojima K; Togo S; Miyanaga T; Hirayama R; Mishima Y
Surg Today; 1996; 26(9):760-1. PubMed ID: 8883258
[TBL] [Abstract][Full Text] [Related]
34. The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy.
Irving JA; Cain G; Howard M; Angus B; Taylor PR; Cattan AR
J Clin Pathol; 1998 Oct; 51(10):776-80. PubMed ID: 10023342
[TBL] [Abstract][Full Text] [Related]
35. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
Godge PY; Poonja LS
Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of elevated serum CD44 levels in patients with oral squamous cell carcinoma.
Sawant S; Ahire C; Dongre H; Joshi S; Jamghare S; Rane P; Kane S; Chaukar D
J Oral Pathol Med; 2018 Aug; 47(7):665-673. PubMed ID: 29752852
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa.
Heider KH; Dämmrich J; Skroch-Angel P; Müller-Hermelink HK; Vollmers HP; Herrlich P; Ponta H
Cancer Res; 1993 Sep; 53(18):4197-203. PubMed ID: 7689929
[TBL] [Abstract][Full Text] [Related]
38. CD44 expression in colorectal cancer. An immunohistochemical study including correlation with cathepsin D immunoreactivity and some tumour clinicopathological features.
Zalewski B; Famulski W; Sulkowska M; Sobaniec-Lotowska M; Piotrowski Z; Kisielewski W; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():152-3. PubMed ID: 11820582
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronate binding assay study of transfected CD44 V4-V7 isoforms into the human gastric carcinoma cell line SC-M1.
Harn HJ; Shen KL; Liu CA; Ho LI; Yang LS; Yueh KC
J Pathol; 1998 Mar; 184(3):291-6. PubMed ID: 9614382
[TBL] [Abstract][Full Text] [Related]
40. Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer.
Müller W; Schneiders A; Heider KH; Meier S; Hommel G; Gabbert HE
J Pathol; 1997 Oct; 183(2):222-7. PubMed ID: 9390037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
